News
October 2006
Sanofi Has No Comment On Acomplia U.S. Launch
31 October 2006 :French drugmaker Sanofi-Aventis
declined to say on Tuesday when it expected to launch anti-obesity pill
Acomplia in the United
States... Read
More...
Gene Therapy May Improve Sexual Function In Diabetic Men
27 October 2006 :Scientists have conducted
successful tests of a gene therapy designed to improve sexual function
in men with diabetes...
Read More...
Viagra May Ease Lung Trouble
26 October 2006 :The drug sildenafil, popularly
known as Viagra, may help
people with chronic obstructive pulmonary disease control the illness-related
blood pressure spikes in the heart's pulmonary artery, a new study found...
Read More...
Eli Lilly to Acquire Cialis Partner Icos
18 October 2006 :Eli Lilly & Co. said Tuesday
that it would buy its partner Icos Corp. for $2.1 billion, acquiring full
marketing rights to Cialis,
the world's second-biggest-selling impotence drug after Viagra...
Read More...
Has
Your Man Lost His Get UP and Go?
18 October 2006 :While there's no getting
away from inevitable changes - an estimated 38 per cent of British men
in their 60s suffer from erectile dysfunction - it's not all bad news...
Read More...
Diet
Drug Acomplia Still Has No Date With Key FDA Advisory Panel
13 October 2006 :The U.S. Food and Drug
Administration on October 10th posted an updated schedule for its advisory
committees with still no indication that a key panel will meet to weigh
the pros and cons of diet drug Acomplia during the final weeks of 2006...
Read More...
Britain
Becomes The Fat Man Of Europe
11 October 2006 :Britain is the fattest
country in Europe, the Government said yesterday as it published the most
comprehensive picture yet of the nation's health...
Read More...
Sanofi
Says U.S. Acomplia Launch Still On Track
06 October 2006 :Sanofi-Aventis reiterated
on Friday that its anti-obesity pill Acomplia
was on track for launch in the United States before the end of 2006...
Read More...
Sexual
Function Of Prostate Cancer Survivors Improved By Cialis
05 October 2006 :In the first randomized
trial of its kind, Tadalafil, a drug typically prescribed for erectile
dysfunction in men, has been proven to increase the sexual function of
prostate cancer survivors, according to a study released...
Read More...
|